5TBG | pdb_00005tbg

The Solution Structure of the Magnesium-bound Conantokin-R1B Mutant

  • Classification: TRANSPORT PROTEIN INHIBITOR
  • Organism(s): Conus
  • Mutation(s): No 

  • Deposited: 2016-09-12 Released: 2017-06-28 
  • Deposition Author(s): Castellino, F.J., Yuan, Y.
  • Funding Organization(s): National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Submitted: 20 

wwPDB Validation 3D Report Full Report

Validation slider image for 5TBG

This is version 1.3 of the entry. See complete history

Literature

Discerning the Role of the Hydroxyproline Residue in the Structure of Conantokin Rl-B and Its Role in GluN2B Subunit-Selective Antagonistic Activity toward N-Methyl-d-Aspartate Receptors.

Yuan, Y.Balsara, R.D.Zajicek, J.Kunda, S.Castellino, F.J.

(2016) Biochemistry 55: 7112-7122

  • DOI: https://doi.org/10.1021/acs.biochem.6b00962
  • Primary Citation Related Structures: 
    5TBG, 5TBQ, 5TBR

  • PubMed Abstract: 

    Conantokins (con) are short γ-carboxyglutamate (Gla)-containing polypeptides expressed by marine snails that function as antagonists of N-methyl-d-aspartate receptor (NMDAR) ion channels. The Gla residues govern structural conformations and antagonistic activities of the conantokins. In addition to Gla, some conantokins, e.g., conRl-B, also contain a hydroxyproline (HyP or O) residue, which in this case is centrally located in the peptide at position 10. Because conRl-B specifically inhibits ion channels of GluN2B subunit-containing heterotetrameric NMDARs, we evaluated the unusual role of HyP 10 in this effect. To accomplish this goal, we examined synthetic variants of conRl-B in which HyP 10 was either deleted (conRl-B[ΔO 10 ]) or replaced with alanine (conRl-B[O 10 A]) or proline (conRl-B[O 10 P]). The solution structures of these variants were determined by nuclear magnetic resonance spectroscopy. Deletion of HyP 10 , or replacement of HyP 10 with Ala 10 , attenuated the distortion in the central region of the apo-conRl-B helix and allowed Mg 2+ -complexed end-to-end α-helix formation. The inhibitory properties of these variants were assessed by measuring NMDA/Gly-stimulated intracellular Ca 2+ influx in mice neurons. ConRl-B[O 10 P] retained its NMDAR ion channel inhibitory activity in wild-type (WT) neurons but lost its GluN2B specificity, whereas conRl-B[ΔO 10 ] showed overall diminished inhibitory function. ConRl-B[O 10 A] showed attenuated inhibitory function but retained its GluN2B specificity. Thus, HyP 10 plays a critical role in maintaining the structural integrity of conRl-B, which can be correlated with its GluN2B subunit-selective inhibition. Weakened inhibition by conRl-B was also observed in neurons lacking either the GluN2C or GluN2D subunit, compared to WT neurons. This suggests that GluN2C and GluN2D are also required for inhibition by conRl-B.


  • Organizational Affiliation
    • W. M. Keck Center for Transgene Research and ‡Department of Chemistry and Biochemistry, University of Notre Dame , Notre Dame, Indiana 46556, United States.

Macromolecule Content 

  • Total Structure Weight: 2.39 kDa 
  • Atom Count: 168 
  • Modeled Residue Count: 20 
  • Deposited Residue Count: 20 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Conantokin-R1B20ConusMutation(s): 0 
UniProt
Find proteins for P0DKZ0 (Conus rolani)
Explore P0DKZ0 
Go to UniProtKB:  P0DKZ0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DKZ0
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
CGU
Query on CGU
A
L-PEPTIDE LINKINGC6 H9 N O6GLU

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Submitted: 20 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)United StatesHL019982

Revision History  (Full details and data files)

  • Version 1.0: 2017-06-28
    Type: Initial release
  • Version 1.1: 2017-09-27
    Changes: Author supporting evidence
  • Version 1.2: 2019-12-04
    Changes: Author supporting evidence, Data collection
  • Version 1.3: 2025-04-02
    Changes: Data collection, Database references, Structure summary